In the recent research, we documented the identification as well as characterization of a completely new atypical opioid receptor with distinctive adverse regulatory Attributes towards opioid peptides.1 Our outcomes showed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can be a broad-spectru